First in-vivo gene therapy administered in ‘historic event’ 05-Mar-2020 By Ben Hargreaves Allergan and Editas commence a first-in-man trial for CRISPR gene therapy for patients with inherited eye condition.
Editas touts manufacturing benefits of teaming up with AskBio 20-Nov-2019 By Nick Taylor Editas Medicine points to AskBio’s ‘excellent manufacturing facility’ and associated expertise to explain benefits of recent partnership.